KIDney Injury in Times of COVID-19 (KIDCOV)

Description

There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the investigators will enroll COVID19-negative and COVID19-positive samples balanced by race/ethnicity from 3 different states, California, Michigan, and Illinois. Study endpoints will be assayed from urine samples mailed to the study team at 2, 6, and 12 months after their date of PCR test, with no requirement for these individuals to leave their homes to participate.

Conditions

SARS-CoV Infection, Covid19, Corona Virus Infection, Acute Kidney Injury, Kidney Injury

Study Overview

Study Details

Study overview

There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the investigators will enroll COVID19-negative and COVID19-positive samples balanced by race/ethnicity from 3 different states, California, Michigan, and Illinois. Study endpoints will be assayed from urine samples mailed to the study team at 2, 6, and 12 months after their date of PCR test, with no requirement for these individuals to leave their homes to participate.

The KIDCOV Study: ASSESSMENT of SARS-CoV-2 Without HOSPITALIZATION as a RISK FACTOR for ACUTE KIDNEY INJURY

KIDney Injury in Times of COVID-19 (KIDCOV)

Condition
SARS-CoV Infection
Intervention / Treatment

-

Contacts and Locations

San Francisco

UCSF, San Francisco, California, United States, 94143

Chicago

Rush University, Chicago, Illinois, United States, 60612

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Result of PCR-based COVID-19 test conducted in the past 4 weeks posted in EMR of participating AMC
  • * Age 18 years or older at enrollment
  • * Race/ethnicity, sex, age, and phone and/or home/email address provided
  • * Failure of a candidate participant to give written informed consent to comply with the study protocol
  • * Hospitalization up to 4 weeks after SARS-CoV-2 test
  • * History of kidney transplant
  • * History of dialysis

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, San Francisco,

Minnie Sarwal, M.D., Ph.D., PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2026-03